Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and CancerPRNewsWire • 03/31/23
Lucid Diagnostics Provides Business Update and Fourth Quarter and Full Year 2022 Financial ResultsPRNewsWire • 03/13/23
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023PRNewsWire • 03/03/23
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic IndustryBusiness Wire • 12/08/22
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer ResearchBusiness Wire • 12/01/22
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial ResultsBusiness Wire • 11/14/22
Lucid Diagnostics to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services ForumBusiness Wire • 11/10/22
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume ManufacturerBusiness Wire • 11/09/22
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022Business Wire • 11/02/22
PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial ResultsBusiness Wire • 08/16/22
Lucid Diagnostics Inc. (LUCD) CEO Lishan Aklog on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/16/22
Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial ResultsBusiness Wire • 08/15/22
Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and OhioBusiness Wire • 08/11/22
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics' EsoGuard® and EsoCheck® TechnologiesBusiness Wire • 08/04/22
Lucid Diagnostics' Laboratory Executes Four New Participating Provider AgreementsBusiness Wire • 08/02/22
Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022Business Wire • 08/01/22
PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy's 2022 Most Influential Black Executives in Corporate AmericaBusiness Wire • 07/19/22
Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 ConferenceBusiness Wire • 07/18/22
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEOBusiness Wire • 05/13/22